• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Stents

Endospan has positive aortic arch stent graft study results

May 5, 2025 By Sean Whooley

Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic arch stent graft system. Results came out of the statistical dissection primary arm from the TRIOMPHE FDA investigational device exemption (IDE) study. Investigators presented findings at the American Association for Thoracic Surgery (AATS) Annual Meeting in Seattle. TRIOMPHE evaluates the […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Stents, Structural Heart Tagged With: endospan, nitinol

Orchestra BioMed wins FDA IDE for sirolimus-angioballoon

April 29, 2025 By Sean Whooley

Orchestra BioMed (Nasdaq:OBIO) announced today that it received FDA investigational device exemption (IDE) for its Virtue drug-coated balloon. It marks the second major regulatory milestone for Orchestra BioMed in just a week. The company last week picked up FDA breakthrough device designation for its atrioventricular interval modulation (AVIM) therapy. FDA IDE enables the company to […]

Filed Under: Cardiovascular, Catheters, Clinical Trials, Drug-Device Combinations, Drug-Eluting Stents Tagged With: Orchestra BioMed

Data backs Boston Scientific drug-eluting stent

April 23, 2025 By Sean Whooley

Boston Scientific today shared study data supporting the use of its Eluvia drug-eluting stent for treating PAD. The company shared multiple new clinical data sets at Charing Cross 2025 in London today. Findings reinforced the growing body of evidence supporting the Eluvia stent for treating peripheral artery disease (PAD) — particularly in the superficial femoral […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Drug-Device Combinations, Featured, Stents, Structural Heart Tagged With: Boston Scientific

R3 Vascular reports first patient treated in next-gen drug-eluting scaffold study

April 22, 2025 By Sean Whooley

R3 Vascular announced today that a doctor treated the first patient in the ELITE-BTK pivotal trial of its drug-eluting bioresorbable scaffold. Dr. Brian DeRubertis of New York-Presbyterian and Weill Cornell Medicine treated the first patient. The trial evaluates the company’s next-generation Magnitude drug-eluting bioresorbable scaffold for below-the-knee peripheral arterial disease (PAD). Mountain View, California-based R3 […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Drug-Eluting Stents, Implants, Stents, Structural Heart, Vascular Tagged With: R3 Vascular

Terumo Neuro wins FDA nod for first dual-layer carotid stent

April 15, 2025 By Sean Whooley

Terumo Neuro (formerly MicroVention) announced today that it received FDA premarket approval (PMA) for its Carotid Stent System. Aliso Viejo, California-based Terumo Neuro says this marks the first dual-layer micromesh carotid stent approved in the U.S. It offers physicians a clinically proven option to improve patient outcomes in carotid artery disease treatment. The stent system […]

Filed Under: Catheters, Stents, Vascular Tagged With: MicroVention, Terumo, Terumo Neuro

Abbott is making an IVL play with FDA IDE nod

March 24, 2025 By Sean Whooley

Abbott announced today that it received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy (IVL) system. IDE enables the company to evaluate the system in treating severe calcification in coronary arteries prior to stenting. The company expects its TECTONIC coronary artery disease (CAD) IVL trial to enroll up to 335 subjects at […]

Filed Under: Cardiovascular, Catheters, Clinical Trials, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Stents Tagged With: Abbott, FDA, intravascular lithotripsy (IVL)

Second Heart Assist says Whisper device caused less hemolysis compared to Abiomed Impella CP

March 11, 2025 By Sean Whooley

Second Heart Assist today announced data from a study highlighting the performance of its Whisper device against a competitive heart pump. The study showed that Whisper — a next-generation percutaneous mechanical circulatory support (pMCS) system — caused significantly less hemolysis than the widely used Johnson & Johnson MedTech/Abiomed Impella CP when both pumps were operated […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Clinical Trials, Stents, Structural Heart Tagged With: Second Heart Assist

Reflow Medical expands global reach with European subsidiary

March 7, 2025 By Sean Whooley

Reflow Medical announced today that it opened a European subsidiary in Landsberg am Lech, Germany, to expand outside the U.S. The company said its strategic expansion strengthens its international presence and enhances its ability to serve markets globally. SVP and GM Knut Saurteig leads the subsidiary, called Reflow Medical Europe GmbH. Under his leadership, the […]

Filed Under: Business/Financial News, Catheters, Stents Tagged With: ReFlow Medical

Philips discontinues Tack endovascular system sales after serious recall

March 4, 2025 By Sean Whooley

The FDA has deemed a recall of the Philips Tack endovascular system Class I, the most serious kind. This recall involves removing devices from use and sale. According to the FDA notice, the device may cause serious injury of death if customers continue to use it. As a result of the recall, Philips plans to […]

Filed Under: Business/Financial News, Cardiovascular, Endoscopic, Featured, Food & Drug Administration (FDA), Implants, Recalls, Regulatory/Compliance, Stents, Vascular Tagged With: FDA, nitinol, Philips, Royal Philips

Biotronik shifts strategy to focus on implantable devices

February 27, 2025 By Sean Whooley

Biotronik today announced a strategic shift that includes the divestiture of its Vascular Intervention (VI) business to Teleflex. This deal comes as part of a major change at Teleflex, too, as the company today announced plans to separate into two separate businesses. Biotronik said its shift aims to strengthen its leadership in active implantable devices […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Drug-Eluting Stents, Featured, MassDevice Earnings Roundup, Stents, Vascular, Wall Street Beat Tagged With: Biotronik, Teleflex

BD warns on atherectomy catheters after deaths

February 10, 2025 By Sean Whooley

BD recently issued a medical device correction later related to its Bard subsidiary’s Rotarex atherectomy system. The company identified a number of anatomical factors that could contribute to catheter helix fracture and/or breakage. It reports 30 serious injuries and four deaths associated with the issue. Additionally, BD reported 115 cases requiring additional intervention following helix […]

Filed Under: Catheters, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Stents, Vascular Tagged With: Bard, BD, FDA

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 79
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy